‘Don’t Apologize for Commercialization’: Biotech Legend Robert Langer Urges Pitt to Take More Risks
Pitt’s Senior Vice Chancellor for Research, Dr. Rob Rutenbar introduced MIT professor Robert Langer... Read more
Pitt’s Senior Vice Chancellor for Research, Dr. Rob Rutenbar introduced MIT professor Robert Langer... Read more
The University of Pittsburgh Office of Innovation and Entrepreneurship (OIE) teamed with its counterparts... Read more
Posted on by Mike Yeomans
A group of 10 University of Pittsburgh faculty spanning numerous schools and departments across the university — from medicine, bioengineering, and nursing to social work, dental medicine, and law — has been selected for the inaugural PittEI3 (Empowering Innovation, Incubation and Impact) Fellowship.
The Pitt Office of Innovation and Entrepreneurship has established PittEI3 with the aim of creating sustainable and equitable institutional change. This was done in recognition of the fact that women and other historically excluded people (HEP) are not participating in the university’s expanding innovation ecosystem to the extent that they are capable of.
Partners in the initiative include the Office of the Senior Vice Chancellor for the Health Sciences, the Office of the Senior Vice Chancellor for Research, the Clinical and Translational Sciences Institute (CTSI), and the Office of the Provost.
The centerpiece of PittEI3 is a new one-year Fellowship for early-to-mid-career Pitt faculty with research responsibilities. Those selected for the inaugural cohort will:
“Innovation flourishes best when a diverse mix of talent, experience and backgrounds is brought to the table. The Pitt EI3 program can invite new people and perspectives into the process and strengthen the culture of innovation and entrepreneurship that is gathering momentum across the University,” said Pitt Chancellor Joan Gabel. “There is impressive collaboration across campus that creates what can become the preeminent model for inclusive innovation across the national higher education landscape.”
The Fellowship was developed and is being directed by Cecelia Yates, associate professor at the Pitt School of Nursing and herself a serial entrepreneur. Dr. Yates is co-founder of Pitt startup company Ocugenix Inc., which last year began a clinical trial for treatment of macular degeneration.
“I am thrilled at the exceptional response to our call for applications for the PittEI3 Fellowship, which made our job to select the inaugural cohort extremely difficult,” Yates said, adding, “We believe we have chosen an incredibly diverse group of faculty representing a broad array of disciplines. We now look forward to surrounding them with the resources and opportunities to explore the potential of their innovations.”
The following individuals are members of the 2024 inaugural cohort of the Pitt EI3 Fellowship: